BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24832446)

  • 1. Pneumococcus adapts to the sickle cell host.
    Mitchell TJ; Mitchell AM
    Cell Host Microbe; 2014 May; 15(5):521-3. PubMed ID: 24832446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.
    Carter R; Wolf J; van Opijnen T; Muller M; Obert C; Burnham C; Mann B; Li Y; Hayden RT; Pestina T; Persons D; Camilli A; Flynn PM; Tuomanen EI; Rosch JW
    Cell Host Microbe; 2014 May; 15(5):587-599. PubMed ID: 24832453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.
    Obert CA; Miller ML; Montgomery J; Adamkiewicz T; Tuomanen EI
    Antimicrob Agents Chemother; 2007 Jan; 51(1):386-9. PubMed ID: 17060526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporin-resistant pneumococci and sickle cell disease.
    Miller ML; Obert CA; Gao G; Daw NC; Flynn P; Tuomanen E
    Emerg Infect Dis; 2005 Aug; 11(8):1192-6. PubMed ID: 16102306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in nasopharyngeal cultures from patients with sickle cell disease.
    Sakhalkar VS; Sarnaik SA; Asmar BI; Conner-Warren R; Shurney W; Abdel-Haq NM
    South Med J; 2001 Apr; 94(4):401-4. PubMed ID: 11332906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal carriage of penicillin-resistant pneumococcus in sickle-cell patients.
    Workman MR; Layton M; Hussein M; Philpott-Howard J; George RC
    Lancet; 1993 Sep; 342(8873):746-7. PubMed ID: 8103856
    [No Abstract]   [Full Text] [Related]  

  • 7. Host-to-Host Transmission of the Pneumococcus-New Victims of a Toxic Relationship.
    Trappetti C; Paton JC
    Cell Host Microbe; 2017 Jan; 21(1):5-6. PubMed ID: 28081444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Infections and Invasive Potential of Nonencapsulated
    Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
    Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
    Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Pneumococcal Factors Affecting Pneumococcal Shedding Shows that the
    Zafar MA; Hammond AJ; Hamaguchi S; Wu W; Kono M; Zhao L; Weiser JN
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcus and sickle cell disease: the beginning of the end?
    Steinberg MH
    Clin Infect Dis; 2007 Jun; 44(11):1434-5. PubMed ID: 17479938
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal infections in children with sickle cell disease: increased incidence, immunological defects, vaccine failure, and prospects for the future.
    Lembo NJ
    J Natl Med Assoc; 1981 Jan; 73(1):43-5. PubMed ID: 7463494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
    Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
    Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal colonization in children with sickle cell disease [see comment].
    Norris CF; Mahannah SR; Smith-Whitley K; Ohene-Frempong K; McGowan KL
    J Pediatr; 1996 Dec; 129(6):821-7. PubMed ID: 8969723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of pneumococcal vaccine in children with sickle-cell disease.
    Ahonkhai VI; Landesman SH; Fikrig SM; Schmalzer EA; Brown AK; Cherubin CE; Schiffman G
    N Engl J Med; 1979 Jul; 301(1):26-7. PubMed ID: 36558
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010-2015.
    Oligbu G; Collins S; Sheppard C; Fry N; Dick M; Streetly A; Ladhani S
    Arch Dis Child; 2018 Jul; 103(7):643-647. PubMed ID: 29282225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections in sickle cell anemia: pathogenesis and control.
    Overturf G; Powars D
    Tex Rep Biol Med; 1980-1981; 40():283-92. PubMed ID: 7034272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pneumococcal vaccination response in children with sickle cell disease: HbSS and HbSC.
    Le Ng X; Alikhan M; Stark JM; Mosquera RA; Shahrukh Hashmi S; Gonzales T; Brown DL; Nguyen TT; Yadav A
    Allergol Immunopathol (Madr); 2019; 47(6):564-569. PubMed ID: 31164233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine.
    Alexander E; Telfer P; Rashid H; Ali KA; Booy R
    J Infect Public Health; 2008; 1(1):40-4. PubMed ID: 20701844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.